original ) (raw )Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
Helena Marzo-ortega
Rheumatology and Therapy, 2020
View PDFchevron_right
Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis
David Sandoval Jacobo
Rheumatology and Therapy, 2019
View PDFchevron_right
Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Athanasios Georgountzos
Therapeutic Advances in Musculoskeletal Disease
View PDFchevron_right
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
Helena Marzo-ortega
The Lancet, 2019
View PDFchevron_right
Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood
Alison Wadeley
Clinical Rheumatology
View PDFchevron_right
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap
Marina Magrey
Rheumatology and Therapy
View PDFchevron_right
Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset
Hedley Griffiths
Clinical Rheumatology
View PDFchevron_right
OP0267-HPR “I Never Thought Exercise Could Help Improve My Sleep”: Experiences of People with Rheumatoid Arthritis on the Impact of Exercise on Sleep
Bente Esbensen
Annals of the Rheumatic Diseases, 2020
View PDFchevron_right
Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review
Alison Wadeley
Rheumatology International
View PDFchevron_right
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: 16 Week Results of a Phase 3 Randomized, Double-Blind, Placebo Controlled Trial in Patients with Prior Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors
Silvia Santisteban
Arthritis & rheumatology (Hoboken, N.J.), 2018
View PDFchevron_right
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled ...
Fidencio Cons-molina
The Lancet
View PDFchevron_right
Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort)
Roberta Ramonda
Rheumatology, 2017
View PDFchevron_right
Sleep disturbances in outpatients with ankylosing spondylitis ± a questionnaire study with gender implications
Ulla Lindqvist , Bjorn Gudbjornsson
View PDFchevron_right
THU0361 Prescription patterns of biological disease modifying drugs and biosimilars in ankylosing spondylitis – a collaboration between biological registers in the five nordic countries
Katerina Chatzidionysiou
Poster Presentations, 2017
View PDFchevron_right
Patient‐Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
Raj Mahapatra
Arthritis Care and Research, 2021
View PDFchevron_right
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: 16 Week Results of a Phase 3 Randomized, Double-Blind, Placebo Controlled Trial in Patients with Prior Inadequate Response or Intolerance to Tumor Necrosis Factor
Silvia Santisteban
Arthritis & Rheumatology, 2019
View PDFchevron_right
Effect of secukinumab on patient-reported outcomes in patients with active ankylosing spondylitis: A Phase 3 randomized trial (MEASURE 1)
vibeke strand
Arthritis & rheumatology (Hoboken, N.J.), 2016
View PDFchevron_right
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis
Sherry Rohekar
The Journal of Rheumatology, 2022
View PDFchevron_right
Assessment of Fatigue in Spondyloarthritis and Its Association with Disease Activity
Pilar Ugalde
The Journal of Rheumatology, 2016
View PDFchevron_right
Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort
Mariagrazia Lorenzin
Arthritis Research & Therapy, 2016
View PDFchevron_right
Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study
Markku J Kauppi
Rheumatology Advances in Practice, 2023
View PDFchevron_right
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial
Joseph Cappelleri
RMD Open, 2022
View PDFchevron_right
Sleep quality and associated factors in ankylosing spondylitis: relationship with disease parameters, psychological status and quality of life
Banu Dilek
Rheumatology International, 2013
View PDFchevron_right
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Vipin Arora
Annals of the Rheumatic Diseases, 2012
View PDFchevron_right
Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis
Bente Esbensen
PLOS ONE, 2020
View PDFchevron_right
Relationship between sleep quality and physical activity level in patients with ankylosing spondylitis
Berna Urkmez
Modern Rheumatology, 2020
View PDFchevron_right
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Mykola Stanislavchuk
Arthritis & rheumatology (Hoboken, N.J.), 2018
View PDFchevron_right
Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe
Orsolya Nagy
Journal of comparative effectiveness research, 2016
View PDFchevron_right
SAT0110 Evaluation of Sleep Quality and the Effects of anti Tnf-Alpha Treatment on Sleep in Rheumatoid Arthritis Patients
Deniz Dülgeroğlu
Annals of the Rheumatic Diseases, 2014
View PDFchevron_right
Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data
Maurizio Muratore
Clinical and Experimental Rheumatology, 2019
View PDFchevron_right
Sleep and rheumatologic disorders
Vivien Abad
Sleep Medicine Reviews, 2008
View PDFchevron_right